Biotech · Private company · Cambridge, MA, US
Sage Therapeutics, Inc.
SEC CIK 0001597553
Track this companyFree. Adds Sage Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials122 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- BrexanolonePhase 3 · Acute Respiratory Distress SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- SAGE-324Phase 3 · Essential TremorClinicalTrials.gov · fetched Nov 12, 2026
- SAGE-547Phase 2 · Essential TremorClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials12
- Utility of Brexanolone to Target Stress-induced Alcohol Use Among Men and Women With Posttraumatic Stress DisorderPHASE1 · ACTIVE_NOT_RECRUITING · started Aug 1, 2023ClinicalTrials.gov NCT05223829 · fetched Nov 12, 2026
- An Open Label Pilot Study of IV Brexanolone for the Treatment of Post-Traumatic Stress DisorderPHASE4 · TERMINATED · started Jun 1, 2023ClinicalTrials.gov NCT05254405 · fetched Nov 12, 2026
- Dynamic Neural Mechanisms of Brexanolone-induced Antidepressant Effects in Postpartum DepressionCOMPLETED · started Aug 5, 2022ClinicalTrials.gov NCT05543746 · fetched Nov 12, 2026
- A Study to Evaluate the Long-term Safety and Tolerability of SAGE-324 in Participants With Essential TremorPHASE2_PHASE3 · TERMINATED · started Jun 3, 2022ClinicalTrials.gov NCT05366751 · fetched Nov 12, 2026
- Effects of Ketamine on ERP/EEG Measures in Healthy VolunteersEARLY_PHASE1 · COMPLETED · started May 26, 2022ClinicalTrials.gov NCT04928703 · fetched Nov 12, 2026
- Effects Zulresso on Postpartum PsychosisEARLY_PHASE1 · COMPLETED · started Feb 23, 2022ClinicalTrials.gov NCT05314153 · fetched Nov 12, 2026
- Study to Evaluate SAGE-324 in Participants With Essential TremorPHASE2 · COMPLETED · started Jan 5, 2022ClinicalTrials.gov NCT05173012 · fetched Nov 12, 2026
- A Study of Brexanolone for Acute Respiratory Distress Syndrome (ARDS) Due to Coronavirus Disease 2019 (COVID-19)PHASE3 · TERMINATED · started Dec 18, 2020ClinicalTrials.gov NCT04537806 · fetched Nov 12, 2026
- A Study to Evaluate the Efficacy, Safety, and Tolerability of SAGE-324 in Participants With Essential TremorPHASE2 · COMPLETED · started May 19, 2020ClinicalTrials.gov NCT04305275 · fetched Nov 12, 2026
- Event-Related Potential (ERP) Biomarkers in Subjects With Schizophrenia and Healthy Volunteer SubjectsCOMPLETED · started Oct 7, 2019ClinicalTrials.gov NCT04025502 · fetched Nov 12, 2026
- Evaluate SAGE-547 in Participants With Essential TremorPHASE2 · COMPLETED · started Sep 23, 2014ClinicalTrials.gov NCT02277106 · fetched Nov 12, 2026
- National Pregnancy Registry for Psychiatric MedicationsRECRUITING · started Nov 1, 2008ClinicalTrials.gov NCT01246765 · fetched Nov 12, 2026
SEC filings12
- 8-K · 8-KSEC EDGAR · filed Jul 31, 2025 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Jul 30, 2025 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jul 30, 2025 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jun 16, 2025 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jun 13, 2025 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Apr 29, 2025 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Apr 29, 2025 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Mar 4, 2025 · fetched Nov 12, 2026
- 10-K · 10-KSEC EDGAR · filed Feb 11, 2025 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Feb 11, 2025 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jan 27, 2025 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jan 13, 2025 · fetched Nov 12, 2026